Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis.
Ontology highlight
ABSTRACT: The tumor microenvironment plays a significant role in colitis-associated cancer (CAC). Intestinal myofibroblasts (IMFs) are cells in the intestinal lamina propria secreting factors that are known to modulate carcinogenesis; however, the physiological role of IMFs and signaling pathways influencing CAC have remained unknown. Tumor progression locus 2 (Tpl2) is a MAPK that regulates inflammatory and oncogenic pathways. In this study we addressed the role of Tpl2 in CAC using complete and tissue-specific ablation of Tpl2 in mutant mice. Tpl2-deficient mice did not exhibit significant differences in inflammatory burdens following azoxymethane (AOM)/dextran sodium sulfate (DSS) administration compared with wild-type mice; however, the mutant mice developed significantly increased numbers and s
SUBMITTER: Koliaraki V
PROVIDER: S-EPMC3484449 | biostudies-literature | 2012 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA